Report: Man died in Polk County jail of blunt force trauma, synthetic cannabinoids – KTRE
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Cannabinoids for Anxiety & Tourette’s: Evidence from Systematic Reviews and Meta-Analyses in Cannabis Research
Systematic reviews and meta-analyses on cannabinoid formulations anxiety disorders reveal mixed evidence with some measurable effects. The quality and consistency of data vary across conditions and formulations. Clinicians should interpret these findings…
Histamine Brain Mapping Study 2026: ADHD, Depression, Schizophrenia
The 2026 histamine brain mapping psychiatric disorders study reveals spatial gene expression patterns linked to ADHD, depression, and schizophrenia. This research integrates gene expression, PET imaging, and psychiatric datasets to create a detailed…
First Placebo-Controlled Trial of Cannabigerol Finds Reduced Anxiety and Stress—But With Important Caveats
The 2024 CBG anxiety stress trial found that a single 20 mg dose of cannabigerol reduced anxiety and stress in healthy adults without intoxication. This placebo-controlled study provides the first controlled human evidence supporting CBG's anxiolytic…
Cannabis and Mental Health: A Review.
A comprehensive JAMA review reveals the stark gap between widespread cannabis use for mental health conditions and actual clinical evidence. While patients commonly self-medicate with cannabis for psychiatric symptoms, this systematic analysis found…
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
A comprehensive scoping review of randomized controlled trials reveals limited high-quality medicinal cannabis mental health evidence for treating psychiatric and substance use disorders. The systematic review highlights significant gaps in rigorous…
Ketamine addiction following a single sub-anaesthetic ketamine treatment for acute suicidality in a psychiatrically multimorbid patient: case report.
A 25-year-old patient developed severe ketamine addiction after single dose treatment for suicidality, highlighting ketamine addiction after single dose treatment risks in vulnerable populations. This case emphasizes the importance of comprehensive…
The efficacy and safety of cannabinoids for mental and substance use disorders: a systematic review and meta-analysis
A landmark cannabinoids mental health disorders systematic review published in The Lancet Psychiatry examines cannabinoids for mental health and substance use disorders. This comprehensive analysis addresses critical evidence gaps. The findings directly…
I can’t be the only one ?
When your patient swears the CBD helped their anxiety, but they also started meditating, cut caffeine, and got 8 hours of sleep for the first time in a decade. Multifactorial outcomes are fun. Via r/trees Further Reading Evidence WatchBrain-body…
Trump’s Psychedelic Executive Order: Symbolic Impact Analyzed
The psychedelic executive order impact is largely symbolic but influences research funding and regulatory pathways. Analysts note limited immediate regulatory changes, yet the order signals federal support for psychedelic medicine research. This policy…
